Avantor® Closes Previously Announced Divestiture of its Clinical Services Business

Go back to Avantor® Closes Previously Announced Divestiture of its Clinical Services Business

Avantor Inc. (AVTR) PT Lowered to $28 at Morgan Stanley

October 21, 2024 8:17 AM EDT

Morgan Stanley analyst Tejas Savant lowered the price target on Avantor Inc. (NYSE: AVTR) to $28.00 (from $29.00) while maintaining a Overweight rating.

The analyst comments "With sentiment bearish on the group on recent data points, inline prints, intact guides & continued evidence of... More